13:29 EST Hoth Therapeutics (HOTH): Enrollment in HT-001 trial proceeding as planned
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HOTH:
- D. Boral says Hoth findings highlight HT-001 potential to ‘revolutionize’ care
- Hoth Therapeutics reports ‘encouraging’ results from Phase 2a trial of HT-001
- Hoth Therapeutics partners with Dept. of Veterans Affairs on obesity treatment
- Biotech Alert: Searches spiking for these stocks today
- Hoth Therapeutics board approves Bitcoin as treasury reserve asset
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
